Clinical Trial Update: CDH1 Germline Mutations in Lobular Breast Cancer

View source ↗

Summary

This clinical trial update indicates that the study on CDH1 germline mutations in lobular breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lobular Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Lobular Breast Carcinoma, CDH1 Gene Inactivation | Status: COMPLETED